Cargando…

Importance of Beta Cell Function for the Treatment of Type 2 Diabetes

Type 2 diabetes (T2DM) is characterized by insulin resistance and beta cell dysfunction. Recent evidence has emerged that beta cell dysfunction is a common pathogenetic feature of both type 1 and type 2 diabetes, and T2DM never develops without beta cell dysfunction. Therefore, treatment of T2DM sho...

Descripción completa

Detalles Bibliográficos
Autor principal:	Saisho, Yoshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449644/ https://www.ncbi.nlm.nih.gov/pubmed/26237486 http://dx.doi.org/10.3390/jcm3030923

Ejemplares similares

Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited
por: Saisho, Yoshifumi
Publicado: (2019)

Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review
por: Inaishi, Jun, et al.
Publicado: (2020)

Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes
por: Saisho, Yoshifumi
Publicado: (2018)

SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
por: Saisho, Yoshifumi
Publicado: (2020)

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes
por: Saisho, Yoshifumi
Publicado: (2016)

Alogliptin benzoate for management of type 2 diabetes
por: Saisho, Yoshifumi
Publicado: (2015)

Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
por: Sugiyama, Kazutoshi, et al.
Publicado: (2018)

Ethnic Similarities and Differences in the Relationship between Beta Cell Mass and Diabetes
por: Inaishi, Jun, et al.
Publicado: (2017)

Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
por: Inaishi, Jun, et al.
Publicado: (2022)

Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes
por: Sasaki, Hironobu, et al.
Publicado: (2021)

Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
por: Sasaki, Hironobu, et al.
Publicado: (2021)

Correction: Sugiyama, K.; et al. Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment. Diseases 2018, 6, 44
por: Sugiyama, Kazutoshi, et al.
Publicado: (2018)

Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
por: Saisho, Yoshifumi
Publicado: (2014)

Type 2 Diabetes and the Aging Pancreatic Beta Cell
por: Gunasekaran, Uma, et al.
Publicado: (2011)

Beta‐cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?
por: Sayyed Kassem, Laure, et al.
Publicado: (2023)

Quantifying beta cell function in the preclinical stages of type 1 diabetes
por: Galderisi, Alfonso, et al.
Publicado: (2023)

The Role of Beta Cell Recovery in Type 2 Diabetes Remission
por: Suleiman, Mara, et al.
Publicado: (2022)

Importance of beta cell mass for glycaemic control in people with type 1 diabetes
por: Jansen, Theodorus J. P., et al.
Publicado: (2022)

Association of visit‐to‐visit glycemic variability with risk of cardiovascular diseases in high‐risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial
por: Sato, Midori, et al.
Publicado: (2021)

Relationship between Stage of Diabetic Retinopathy and Pulse Wave Velocity in Japanese Patients with Type 2 Diabetes
por: Tanaka, Kumiko, et al.
Publicado: (2013)

Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study
por: Inaishi, Jun, et al.
Publicado: (2022)

Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial
por: Sato, Seiji, et al.
Publicado: (2015)

Role of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes
por: Wang, Hong-Lian, et al.
Publicado: (2022)

Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults
por: Sasaki, Hironobu, et al.
Publicado: (2020)

Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes
por: Infante, Marco, et al.
Publicado: (2019)

Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?
por: Veelen, Anna, et al.
Publicado: (2020)

Epigenetic aspects of pancreatic beta cell function in type 2 diabetes
por: Cnop, Miriam
Publicado: (2014)

Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells
por: Gurgul-Convey, Ewa
Publicado: (2020)

Integration of nano‐ and biotechnology for beta‐cell and islet transplantation in type‐1 diabetes treatment
por: Dinnyes, Andras, et al.
Publicado: (2020)

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis
por: Sugiyama, Kazutoshi, et al.
Publicado: (2019)

Linking Metabolic Abnormalities to Apoptotic Pathways in Beta Cells in Type 2 Diabetes
por: Wali, Jibran A., et al.
Publicado: (2013)

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

The Importance of REST for Development and Function of Beta Cells
por: Martin, David, et al.
Publicado: (2017)

Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Emerging Anti-Diabetic Drugs for Beta-Cell Protection in Type 1 Diabetes
por: Ajmal, Nida, et al.
Publicado: (2023)

Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients
por: Tanaka, Masami, et al.
Publicado: (2014)

Importance of Both Imprinted Genes and Functional Heterogeneity in Pancreatic Beta Cells: Is There a Link?
por: Chabosseau, Pauline, et al.
Publicado: (2021)

Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes?
por: Rodriguez-Rodriguez, Ana Elena, et al.
Publicado: (2021)

Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus
por: Klinke, David J.
Publicado: (2008)

The Importance of Global Studies of the Genetics of Type 2 Diabetes
por: McCarthy, Mark I.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7tet8p121kgnp8s73ga7vplhaa